Abstract:Abstract Background Cancer-associated fibroblasts (CAFs) and vasculogenic mimicry (VM) play important roles in the occurrence and development of tumors. However, the relationship between CAFs and VM formation, especially in gallbladder cancer (GBC) has not been clarified. In this study, we investigated whether gallbladder CAFs (GCAFs) can promote VM formation and tumor growth and explored the underlying molecular mechanism. Methods A co-culture system of human GBC cells and fibroblasts or HUVECs was established. VM formation, proliferation, invasion, migration, tube formation assays, CD 31 -PAS double staining, optic/electron microscopy and tumor xenograft assay were used to detect VM formation and malignant phenotypes of 3-D co-culture matrices in vitro, as well as the VM formation and tumor growth of xenografts in vivo, respectively. Microarray analysis was used to analyze gene expression profile in GCAFs/NFs and VM (+)/VM (−) in vitro. QRT-PCR, western blotting, IHC and CIF were used to detected NOX4 expression in GCAFs/NFs, 3-D culture/co-culture matrices in vitro, the xenografts in vivo and human gallbladder tissue/stroma samples. The correlation between NOX4 expression and clinicopathological and prognostic factors of GBC patients was analyzed. And, the underlying molecular mechanism of GCAFs promoting VM formation and tumor growth in GBC was explored. Results GCAFs promote VM formation and tumor growth in GBC; and the finding was confirmed by facts that GCAFs induced proliferation, invasion, migration and tube formation of GBC cells in vitro, and promoted VM formation and tumor growth of xenografts in vivo. NOX4 is highly expressed in GBC and its stroma, which is the key gene for VM formation, and is correlated with tumor aggression and survival of GBC patients. The GBC patients with high NOX4 expression in tumor cells and stroma have a poor prognosis. The underlying molecular mechanism may be related to the upregulation of NOX4 expression through paracrine IL-6 mediated IL-6/JAK/STAT3 signaling pathway. Conclusions GCAFs promote VM formation and tumor growth in GBC via upregulating NOX4 expression through the activation of IL-6-JAK-STAT3 signal pathway. NOX4, as a VM-related gene in GBC, is overexpressed in GBC cells and GCAFs, which is related to aggression and unfavorable prognosis of GBC patients.

FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis

Correction: FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis

Expression Of Fgf19/Fgfr4 Related Biomarkers In Hepatocellular Carcinoma

Expression of pGSK-3α/β (Tyr279/216) and XIAP proteins in cholangiocarcinoma and their clinical significance

Abstract 3131: Expression of FGF19/FGFR4 related biomarkers in hepatocellular carcinoma

Identification of the prognostic value of elevated ANGPTL4 expression in gallbladder cancer‐associated fibroblasts

Prognostic Implications of Estrogen Receptor 1 and Vascular Endothelial Growth Factor A Expression in Primary Gallbladder Carcinoma.

Fibronectin Promotes Cell Proliferation and Invasion Through Mtor Signaling Pathway Activation in Gallbladder Cancer.

Expressions of Farnesoid X Receptor and Myeloid Cell Leukemia Sequence 1 Protein Are Associated with Poor Prognosis in Patients with Gallbladder Cancer.

Downregulated Expression of Hepatoma-Derived Growth Factor (HDGF) Reduces Gallbladder Cancer Cell Proliferation and Invasion

Fibroblast Growth Factor Receptor 4 Promotes Progression And Correlates Cross Mark To Poor Prognosis In Cholangiocarcinoma

Impact of Bile Acids on the Growth of Human Cholangiocarcinoma Via FXR

Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway

Abnormal Inflammatory Status Promotes Lymphatic Metastasis of Gallbladder Cancer Cells Through the CACUL1/NRF2/ITGBL1/ITGA9/VEGF-C Pathway

Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment

FGFBP1 as a potential biomarker predicting bacillus Calmette–Guérin response in bladder cancer

Overexpression of LAPTM4B Promotes Growth of Gallbladder Carcinoma Cells in Vitro

Upregulated NOX1 Expression in Gallbladder Cancer‑associated Fibroblasts Predicts a Poor Prognosis

BRD9 promotes the progression of gallbladder cancer via CST1 upregulation and interaction with FOXP1 through the PI3K/AKT pathway and represents a therapeutic target

Mining of RNA Methylation-Related Genes and Elucidation of Their Molecular Biology in Gallbladder Carcinoma